Product information

From Health Canada

Note - The product information found within this database originates from organizations not subject to the Official Languages Act and is available in the language in which it was written and submitted to Health Canada.

Note - The market status of a product is now available in the LNHPD and identifies if a product is "marketed" or "not marketed" in Canada. Product licence holders may voluntarily provide the Natural and Non-Prescription Health Products Directorate (NNHPD) with information about whether their product is currently available to Canadian consumers. Where no information has been provided, the default status is "not marketed". The "current status" field remains unaffected and will continue to indicate the status of the product licence (i.e., active, discontinued, stop sale, cancelled, or suspended). Note that where a licence has been suspended, cancelled or under stop sale, the product cannot be legally sold in Canada.

Product licence holders - if you wish to update a product's market status, you are invited to complete the Natural Health Products Market Notification Web Form. As with all other notifications, there is no current service standard. The NNHPD will process the market status update as soon as feasible, based on its available resources. As a reminder, market notification is voluntary; therefore, a licence holder is not required to wait for the LNHPD to be updated before a licensed product is sold in Canada. As such, products that are identified in the LNHPD as "not marketed" may still be sold in Canada.

New search

Natural Product Number (NPN):
80084259
Market status:
Marketed
Licence Status:
Active
Brand name(s):
Bile Salts with Lipase ;
Bile-Force ;
Keto Enzyme
Licence holder:
Prairie Naturals Health Products Inc.
Dosage Form:
Capsule
Recommended route of administration:

Oral

Recommended dose:
Sub population (Sub Pop.) Quantity (Qty) Frequency (Freq.)
Sub Pop. Age Min. Max. UoM Footnote1 Age Qty Min. Max. UoM Qty Freq. Min. Max. UoM Freq.
Adults 2.0 capsule 1 2 daily
Recommended use or purpose:
Digestive enzyme. Digestive aid. Digestive aid to help decrease bloating after high caloric, high fat meals. Helps to decrease bloating after high caloric, high in fat meals.
Risk Information:
Cautions and Warnings 
Take with water and maintain adequate fluid intake. Take a few hours before or after taking other medications. If symptoms persist or worsen, consult a health care practitioner. Do not use if you are pregnant or breastfeeding, if you suffer from gastric reflux, or if you have gastrointestinal lesions/ulcers, if you have esophageal obstruction, a liver disorder, gastrointestinal tract or gallbladder disorders, gallstones, a bile duct obstruction and/or bowel obstruction. If you are sensitive to pancreatic enzymes, do not use this product. If you have diabetes, pacreatitis, pancreatic exocrine insufficiency or cystic fibrosis, consult a health care practitioner prior to use. Hypersensitivity/allergy has been known to occur; in which case, discontinue use. Nausea, vomiting, abdominal pain/epigastric pain and/or heartburn have been known to occur, in which case discontinue use (and consult a health care practitioner). Use the smallest effective dose which contols symptoms. Consult a health care practitioner for use beyond four weeks. For prolonged use, consult a health care practitioner.
List of medicinal ingredients:
Medicinal ingredients Quantity (Qty) Extract Potency
Bile salts 50.0 mg
Pancreatic extract 50.0 mg
10000.0   USP units
Amylase
10000.0   USP units
Protease
1600.0   USP units
Lipase
Triacylglycerol lipase 78.44 mg
800.0   FCC LU
Ulmus rubra 80.0 mg
List of non-medicinal ingredients:
  • Gelatin
  • Magnesium Stearate
  • Microcrystalline cellulose
Date of licensing:
2018-04-06
Revised date of licence:
2024-01-17

Application information

Related information

Compendium of monographs

Contact us

For technical support or if you have general questions concerning the content of this database, please contact the Natural Health Products Directorate (NHPD).

"Page details"

Date modified: